Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Environmental Health Perspectives|August 28, 2023
Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?Jay S SchneiderPlos One|June 15, 2018
Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's diseaseJay S SchneiderInternational Journal of Molecular Sciences|June 10, 2023
GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic MechanismsJay S SchneiderMolecular and Cellular Neurosciences|January 7, 2019
siRNA-mediated knockdown of B3GALT4 decreases GM1 ganglioside expression and enhances vulnerability for neurodegenerationMegha Verma, Jay S SchneiderNPJ Parkinson'S Disease|June 8, 2026
Sleep-circadian modulation of autophagy and glymphatic function: failure of coordinated brain clearance in Parkinson's diseaseShamaila Zafar, Jay S SchneiderNeuropharmacology|November 14, 2021
Current concepts in treating mild cognitive impairment in Parkinson's diseaseJay S Schneider, Sandhya KortagereFrontiers in Molecular Neuroscience|December 12, 2022
Altered expression of glycobiology-related genes in Parkinson's disease brainJay S Schneider, Garima SinghBrain Research|July 27, 2010
Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibitionSarah K Kidd, Jay S SchneiderBrain Research|August 15, 2002
GABA(A) and mu-opioid receptor binding in the globus pallidus and endopeduncular nucleus of animals symptomatic for and recovered from experimental ParkinsonismJoseph A Schroeder, Jay S SchneiderBrain : a Journal of Neurology|December 13, 2002
Lead neurotoxicity in children: basic mechanisms and clinical correlatesTheodore I Lidsky, Jay S SchneiderPageof 7